Ravi Paluri to Carcinoma, Pancreatic Ductal
This is a "connection" page, showing publications Ravi Paluri has written about Carcinoma, Pancreatic Ductal.
Connection Strength
2.336
-
Manne A, Kasi A, Esnakula AK, Paluri RK. Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence. Int J Mol Sci. 2023 Apr 30; 24(9).
Score: 0.871
-
Paluri R, Laursen A, Gaeta J, Wang S, Surinach A, Cockrum P. Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States. Oncologist. 2022 Jun 08; 27(6):e518-e523.
Score: 0.819
-
Kim H, Morgan DE, Schexnailder P, Navari RM, Williams GR, Bart Rose J, Li Y, Paluri R. Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom: A Pilot Study. Invest Radiol. 2019 01; 54(1):16-22.
Score: 0.646